share_log

港股CXO板块集体走强:昭衍新药涨近7%,金斯瑞涨超5%

The CXO sector of Hong Kong stocks strengthened collectively: Zhaoyan Pharmaceutical rose nearly 7%, and Kingsley rose more than 5%

Gelonghui Finance ·  May 6 10:30
Glonghui, May 6 | Hong Kong pharmaceutical stocks rose as a whole. Among them, innovative drugs and CXO showed the most prominent performance. In terms of individual CXO stocks, Zhaoyan Pharmaceutical, Kanglong Chemical, Pharmaceutical and Tiger Pharmaceuticals rose more than 6%, Kingsley rose more than 5%, Gloria Ying rose nearly 5%, and Pharmaceutical Kangde rose more than 3%.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment